Kenya reported its first confirmed case of Bundibugyo Ebola on October 6, 2026, after a Kenyan citizen who had lived in the Democratic Republic of Congo for seven years died at Nairobi Hospital. The patient, a Kenyan national, had been experiencing symptoms for about a month before traveling back to Kenya.
The patient journeyed by road through Uganda before boarding JamboJet flight 8523 to Nairobi on October 3. Upon arrival at Jomo Kenyatta International Airport, the patient was screened and taken directly to isolation as a precautionary measure. Laboratory analysis at the National Virology Reference Laboratory and the Kenya Medical Research Institute later confirmed the presence of the Bundibugyo strain.
The Bundibugyo strain is a relatively rare Ebola variant previously seen in Uganda and the Democratic Republic of Congo. According to health officials, the virus's case-fatality rate is estimated at 30-40 percent, which is lower than the Zaire strain. The patient received supportive care but unfortunately died on Monday night.
Despite the fatal outcome, health officials have been swift in their response, identifying 28 close contacts, including relatives and healthcare workers. They are also tracing 23 passengers and four crew members from the same flight, placing those at risk under monitoring or quarantine. So far, more than 652,000 travelers have been screened and 267 samples tested since the regional outbreak began.
There is currently no approved vaccine or specific treatment for Bundibugyo Ebola. The World Health Organization says research continues, and outbreak control relies on rapid detection, isolation, contact tracing, infection-prevention measures, and safe burials. Authorities are urging the public not to panic, emphasizing that Ebola is not spread by casual proximity.
Health officials advise the public to take precautions, such as frequent hand washing, avoidance of close contact with sick travelers, and prompt medical attention for concerning symptoms. The virus is thought to reside in fruit bats, and human infection occurs through close contact with infected animals or bodily fluids, with transmission possible in healthcare settings lacking adequate infection-prevention measures.
The Kenyan government has heightened surveillance and is working closely with international health organizations to contain the outbreak. The public is being reassured that measures are in place to prevent the spread of the virus and that the situation is being closely monitored.
Key points
- The patient, a Kenyan national, had lived in the Democratic Republic of Congo for seven years before traveling back to Kenya.
- The Bundibugyo strain has a case-fatality rate of 30-40 percent.
- There is currently no approved vaccine or specific treatment for Bundibugyo Ebola.
